Literature DB >> 10849482

Hormonal deficiency in elderly males.

S Z Qian1, Y Cheng Xu, J Zhang.   

Abstract

During the aging process, a number of morphological and neurochemical alterations have been found in the supra-chiasmatic nuclei, which are in part responsible for the age-dependent decrease in plasma testosterone (andropause or PADAM), DHEA (adrenopause), GH/IGF-I (somatopause) and melatonin that develops in most men at about the age of 50 (Perry, 1999; Vermeulen et al., 1999). An important principle in antiaging practice is the employment of the best of available means to prevent the preventable and delay the inevitable. Therefore, some scientists advocate multihormonal replacement therapy and the use of antioxidant drugs that may favourably influence some of the pathological conditions in aging men.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849482     DOI: 10.1046/j.1365-2605.2000.00001.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  2 in total

Review 1.  Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review.

Authors:  Marc Bienz; Fred Saad
Journal:  Bonekey Rep       Date:  2015-06-24

Review 2.  Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review.

Authors:  Tae Jin Kim; Kyo Chul Koo
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.